• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J.Inf.Dis. Complications and associated bacterial co-infections among children hospitalized with seasonal or pandemic influenza, United States, 2003-2

tetano

Editor, Senior Moderator
Complications and associated bacterial co-infections among children hospitalized with seasonal or pandemic influenza, United States, 2003-2010

Fatimah S. Dawood1,
Sandra S. Chaves1,
Alejandro P?rez1,
Arthur Reingold2,
James Meek3,
Monica M. Farley4,
Patricia Ryan5,
Ruth Lynfield6,
Craig Morin6,
Joan Baumbach7,
Nancy M. Bennett8,
Shelley Zansky9,
Ann Thomas10,
Mary Lou Lindegren11,
William Schaffner11,
Lyn Finelli1,
for the Emerging Infections Program Network

+ Author Affiliations

1Influenza Division, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA
2California Emerging Infections Program, Oakland, California, USA
3Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA
4Emory University School of Medicine, the Atlanta Veterans Affairs Medical Center, and the Georgia Emerging Infections Program, Atlanta, Georgia, USA
5Maryland Department of Health and Mental Hygiene, Baltimore, MD
6Minnesota Department of Health, St. Paul, Minnesota, USA
7New Mexico Department of Health, Santa Fe, New Mexico, USA
8Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
9Emerging Infections Program, New York State Department of Health, Albany, NY, USA
10Oregon Public Health Division, Portland, Oregon, USA
11Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee

Corresponding Author: Fatimah S. Dawood, Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Rd MS A-32, Atlanta, GA 30333, United States; telephone: (404) 639-0431; fax (404) 639-3866; email: fdawood@cdc.gov.

Alternate Corresponding Author: Lyn Finelli, DrPH, Tel: 404.639.2554, Email: lyf8@cdc.gov.

Abstract

Background. Data on the range and severity of influenza-associated complications among children are limited. We describe the frequency and severity of complications in hospitalized children aged <18 years with seasonal influenza (2003-2009) and influenza A(H1N1)pdm09 (2009-2010).

Methods. Population-based surveillance for laboratory-confirmed influenza hospitalizations was conducted among 5.3 million children in 10 states. Complications were identified by ICD-9 codes in medical records.

Results. During 2003-2010, 7,293 children hospitalized with influenza were identified, of whom 6,769 (93%) had complete ICD-9 code data. Among the 6,769 children, the median length of hospitalization was 3 days (interquartile range 2-4), 975 (14%) required intensive care, 359 (5%) had respiratory failure, and 40 (1%) died. The most common complications were pneumonia (28%), asthma exacerbations (793/3616 children >2 years, 22%), and dehydration (21%). Lung abscess/empyema, tracheitis, encephalopathy, bacteremia/sepsis, acute renal failure, and myocarditis were rare (<2%) but associated with median hospitalization >6 days and 48-70% of children required intensive care. Positive bacterial cultures were identified in 2% of children (107/6769); Staphylococcus aureus and Streptococcus pneumoniae were most commonly identified.

Conclusion. Complications add substantially to the burden of hospitalized children with influenza through intensive care requirements and prolonged hospitalization, highlighting the importance of primary prevention with influenza vaccination.


http://jid.oxfordjournals.org/content/early/2013/08/27/infdis.jit473.abstract
 
Back
Top Bottom